← Back
Data updated: Mar 29, 2026
CONCORDIA
Oncology
Specialty
CONCORDIA is a specialty pharmaceutical company focused on Oncology.
1958
Since
2
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
0 drugs Phase 1: 2
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Active (0)
Discontinued (2)
Company Info
- First Approval
- 1958-06-05
- Latest
- 2022-01-14
- Applications
- 2